Hatfield, United Kingdom

Allen Edward Goodship

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Quy Biosciences Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allen Edward Goodship. Retrieved from https://idiyas.com/inventor/allen-edward-goodship

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Allen Edward Goodship: Innovator in Pharmaceutical Technology

Introduction

Allen Edward Goodship is a notable inventor based in Hatfield, GB. He has made significant contributions to the field of pharmaceutical technology, particularly in the area of regenerative medicine. His innovative work focuses on the use of mesenchymal stem cells for treating soft tissue injuries.

Latest Patents

Goodship holds a patent for "Pharmaceutical kits comprising mesenchymal stem cells." This patent describes a method of treating natural soft skeletal tissue injuries in patients. The method involves administering a composition of mesenchymal stem cells in a liquid suspension that is enriched compared to the natural source of these cells, or tenocytes derived from them. This technique is particularly effective for regenerating tendons in competitive mammals, such as the superficial digital flexor tendon of horses.

Career Highlights

Goodship is associated with Quy Biosciences Limited, where he applies his expertise in stem cell technology. His work has the potential to revolutionize treatments for soft tissue injuries, enhancing recovery in both human and animal patients.

Collaborations

Some of his notable coworkers include Roger Kenneth Whealands Smith and Kenneth Gregory McGarrell. Their collaborative efforts contribute to the advancement of research and development in the field of regenerative medicine.

Conclusion

Allen Edward Goodship's innovative approach to using mesenchymal stem cells represents a significant advancement in the treatment of soft tissue injuries. His contributions to pharmaceutical technology are paving the way for new therapeutic options in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…